102 related articles for article (PubMed ID: 11754111)
41. Spectrum and prevalence of BRCA1 and BRCA2 germline mutations in Sardinian patients with breast carcinoma through hospital-based screening.
Palomba G; Pisano M; Cossu A; Budroni M; Dedola MF; Farris A; Contu A; Baldinu P; Tanda F; Palmieri G
Cancer; 2005 Sep; 104(6):1172-9. PubMed ID: 16047344
[TBL] [Abstract][Full Text] [Related]
42. High frequency of somatic missense mutation of BRCA2 in female breast cancer from Taiwan.
Chen FM; Hou MF; Chang MY; Wang JY; Hsieh JS; Ou-Yang F; Huang TJ; Lin SR
Cancer Lett; 2005 Apr; 220(2):177-84. PubMed ID: 15766593
[TBL] [Abstract][Full Text] [Related]
43. High proportion of BRCA1/2 founder mutations in Hispanic breast/ovarian cancer families from Colombia.
Torres D; Rashid MU; Gil F; Umana A; Ramelli G; Robledo JF; Tawil M; Torregrosa L; Briceno I; Hamann U
Breast Cancer Res Treat; 2007 Jun; 103(2):225-32. PubMed ID: 17080309
[TBL] [Abstract][Full Text] [Related]
44. The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
Cao AY; Huang J; Hu Z; Li WF; Ma ZL; Tang LL; Zhang B; Su FX; Zhou J; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Yuan WT; Shen ZZ; Huang W; Shao ZM
Breast Cancer Res Treat; 2009 Apr; 114(3):457-62. PubMed ID: 18446436
[TBL] [Abstract][Full Text] [Related]
45. Prognostic significance of germline BRCA2 mutations in hereditary breast cancer patients.
Verhoog LC; Berns EM; Brekelmans CT; Seynaeve C; Meijers-Heijboer EJ; Klijn JG
J Clin Oncol; 2000 Nov; 18(21 Suppl):119S-24S. PubMed ID: 11060339
[TBL] [Abstract][Full Text] [Related]
46. Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancer.
Lehman TA; Haffty BG; Carbone CJ; Bishop LR; Gumbs AA; Krishnan S; Shields PG; Modali R; Turner BC
Cancer Res; 2000 Feb; 60(4):1062-9. PubMed ID: 10706125
[TBL] [Abstract][Full Text] [Related]
47. [The identification of a new mutation in the BRCA2 gene by protein truncation analysis in a Spanish family with hereditary breast cancer].
Díez O; del Río E; Domènech M; Sanz J; Cortés J; Brunet J; Alonso Mdel C; Baiget M
Med Clin (Barc); 1999 Feb; 112(5):179-81. PubMed ID: 10091212
[TBL] [Abstract][Full Text] [Related]
48. BRCA2 germline mutations in male breast cancer patients in the Polish population.
Kwiatkowska E; Teresiak M; Lamperska KM; Karczewska A; Breborowicz D; Stawicka M; Godlewski D; Krzyzosiak WJ; Mackiewicz A
Hum Mutat; 2001; 17(1):73. PubMed ID: 11139248
[TBL] [Abstract][Full Text] [Related]
49. Prevalence of BRCA1 mutations in familial and sporadic greek ovarian cancer cases.
Stavropoulou AV; Fostira F; Pertesi M; Tsitlaidou M; Voutsinas GE; Triantafyllidou O; Bamias A; Dimopoulos MA; Timotheadou E; Pectasides D; Christodoulou C; Klouvas G; Papadimitriou C; Makatsoris T; Pentheroudakis G; Aravantinos G; Karydakis V; Yannoukakos D; Fountzilas G; Konstantopoulou I
PLoS One; 2013; 8(3):e58182. PubMed ID: 23536787
[TBL] [Abstract][Full Text] [Related]
50. A novel BRCA2 in frame deletion in a Tunisian woman with early onset sporadic breast cancer.
Hadiji-Abbes N; Trifa F; Choura M; Khabir A; Sellami-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R
Pathol Biol (Paris); 2015 Sep; 63(4-5):185-9. PubMed ID: 26320393
[TBL] [Abstract][Full Text] [Related]
51. Familial aggregation of breast cancer with early onset lung cancer.
Schwartz AG; Siegfried JM; Weiss L
Genet Epidemiol; 1999 Nov; 17(4):274-84. PubMed ID: 10520210
[TBL] [Abstract][Full Text] [Related]
52. Can unknown predisposition in familial breast cancer be family-specific?
Lynch H; Wen H; Kim YC; Snyder C; Kinarsky Y; Chen PX; Xiao F; Goldgar D; Cowan KH; Wang SM
Breast J; 2013; 19(5):520-8. PubMed ID: 23800003
[TBL] [Abstract][Full Text] [Related]
53. BRCA2 germline mutations in familial pancreatic carcinoma.
Hahn SA; Greenhalf B; Ellis I; Sina-Frey M; Rieder H; Korte B; Gerdes B; Kress R; Ziegler A; Raeburn JA; Campra D; Grützmann R; Rehder H; Rothmund M; Schmiegel W; Neoptolemos JP; Bartsch DK
J Natl Cancer Inst; 2003 Feb; 95(3):214-21. PubMed ID: 12569143
[TBL] [Abstract][Full Text] [Related]
54. The prevalence of BRCA2 mutations in familial pancreatic cancer.
Couch FJ; Johnson MR; Rabe KG; Brune K; de Andrade M; Goggins M; Rothenmund H; Gallinger S; Klein A; Petersen GM; Hruban RH
Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):342-6. PubMed ID: 17301269
[TBL] [Abstract][Full Text] [Related]
55. BRCA2 gene mutations in families with aggregations of breast and stomach cancers.
Jakubowska A; Nej K; Huzarski T; Scott RJ; Lubiński J
Br J Cancer; 2002 Oct; 87(8):888-91. PubMed ID: 12373604
[TBL] [Abstract][Full Text] [Related]
56. Breast cancer and the MNSs blood groups.
Phipps RF; Perry RM
Dis Markers; 1989; 7(4):253-6. PubMed ID: 2582715
[TBL] [Abstract][Full Text] [Related]
57. Recurrent Germline BRCA2 Gene Mutation in Lithuanian Family.
Sadzevičienė I; Jarmalaitė S; Besusparis J; Liaugaudienė O; Asadauskienė J; Brasiūnienė B; Kulikienė I; Sabaliauskaitė R
Medicina (Kaunas); 2020 Mar; 56(3):. PubMed ID: 32164353
[TBL] [Abstract][Full Text] [Related]
58. Double Heterozygosity of BRCA2 and STK11 in Familial Breast Cancer Detected by Exome Sequencing.
Ataei-Kachouei M; Nadaf J; Akbari MT; Atri M; Majewski J; Riazalhosseini Y; Garshasbi M
Iran J Public Health; 2015 Oct; 44(10):1348-52. PubMed ID: 26576347
[TBL] [Abstract][Full Text] [Related]
59. Minor role of BRCA2 mutation (Exon2 and Exon11) in patients with early-onset breast cancer amongst Iranian Azeri-Turkish women.
Karimian Fathi N; Shekari Khaniani M; Montazeri V; Mansoori Derakhshan S
Iran J Basic Med Sci; 2014 Feb; 17(2):108-11. PubMed ID: 24711893
[TBL] [Abstract][Full Text] [Related]
60. Is BRCA2 c.9079 G>A a predisposing variant for early onset breast cancer?
Hammet F; George J; Tesoriero AA; Jenkins MA; Schroen C; Smith L; Grabosch-Meehan A; Dite G; McCredie MR; Giles GG; Tavtigian SV; Hopper JL; Southey MC
Breast Cancer Res Treat; 2008 May; 109(1):177-9. PubMed ID: 17549625
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
